Kura Oncology Inc (KURA)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO, CA 92121

Kura Oncology, Inc. operates as a clinical stage biopharmaceutical company. The Company focuses on discovery and development of personalized therapeutics for the treatment of tumors and blood cancers. Kura Oncology offers development programs for cancers with high unmet need, including lung, colorectal, thyroid, blood, and pancreatic cancers.

Data based on most recent fiscal year report
Market Cap575.111 Million Shares Outstanding45.32 Million Avg Volume358.066 Thousand
1-Yr BETA vs S&P TR1.416 Current Ratio13.3 Quick Ratio13.3
View SEC Filings from KURA instead.

View recent insider trading info

Funds Holding KURA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding KURA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

STEIN STEVEN H EVP & CHIEF MEDICAL OFFICER

  • Officer
0 2020-01-17 1

SZELA MARY T

  • Director
0 2020-01-10 1

NORTH ANNETTE EVP, GENERAL COUNSEL & SECTY.

  • Officer
0 2020-01-06 0

FLOWERS KIRSTEN CHIEF COMMERCIAL OFFICER

  • Officer
0 2020-01-06 2

HASNAIN FAHEEM

3,000 2020-01-03 1

HOFFMAN ROBERT CFO & SVP, FINANCE

  • Officer
0 2019-12-19 1

BASTA JAMES CHIEF LEGAL OFFICER

  • Officer
0 2019-11-04 2

PARKS DIANE L.

  • Director
0 2019-10-14 2

FORD KATHLEEN CHIEF OPERATING OFFICER

  • Officer
0 2019-08-09 2

PAPPAJOHN JOHN

  • Director
  • 10% Owner
1,132,925 2019-07-16 0

GUALBERTO ANTONIO HEAD OF DEVELOPMENT & CMO

  • Officer
339,973 2019-07-10 1

MALLEY THOMAS

  • Director
0 2019-06-25 1

WILSON TROY EDWARD

  • Director
26,145 2019-06-10 0

REN PINGDA SVP CHEMISTRY&PHARMA SCIENCES

  • Officer
0 2019-01-22 0

FARNAM JOHN CHIEF OPERATING OFFICER

  • Officer
0 2019-01-22 0

GRASSO MARC CFO, CBO

  • Officer
0 2019-01-22 0

ECOR1 CAPITAL FUND QUALIFIED, L.P.

  • 10% Owner
4,408,097 2018-12-17 0

HENSON HEIDI CHIEF FINANCIAL OFFICER

  • Officer
0 2018-01-24 0

LIU YI CHIEF SCIENTIFIC OFFICER

  • Officer
0 2018-01-24 0

KINLEY MATTHEW P

  • Director
314,241 2015-12-09 0

VASSILIOU ARGYRIS

  • 10% Owner
No longer subject to file 2015-03-06 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

FLOWERS KIRSTEN - Officer CHIEF COMMERCIAL OFFICER

2020-01-06 A 250,000 a 250,000 0.00 direct

**EXPERIMENTAL** Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin

Short Position History

Holder Net Short Position Position Date Origin
Squarepoint Ops LLC Kura Sushi Inc. 0.58% 2019-09-02 UK
Squarepoint Ops LLC Kura Sushi Inc. 0.69% 2019-08-15 UK
Click here to report any possible errors with this stock listing.

Elevate your investments